TABLE 1.
USP7 substrates | Processes | Related cancer | References |
---|---|---|---|
EBNA1 | Viral proteins | Holowaty et al.,2003 | |
ICP0 | Pfoh et al.,2015 | ||
vIRFs | Chavoshi et al., 2016; Xiang et al.,2018 | ||
LANA | Jager et al.,2012 | ||
E1B-55K | Ching et al.,2013 | ||
Tat | Ali et al.,2017 | ||
Foxp3 | Immune response | Non-small cell lung cancer | van Loosdregt et al., 2013; Wang L. et al.,2016 |
TRIM27 | Cervical carcinoma | Cai et al.,2018 | |
NLRP3 | Leukemia | Palazon-Riquelme et al.,2018 | |
C-Myc and N-Myc | Oncoproteins | Neuroblastoma | Bhattacharya and Ghosh,2015 |
p53 | Tumor suppressor proteins | Ovarian cancers | Oliner et al., 1992; Li et al.,2002 |
DAXX | Breast cancer | Tang et al.,2006 | |
PTEN | Chronic lymphocytic leukemia | Morotti et al.,2014 | |
FOXOs family | Lung carcinoma | Huang et al.,2005 | |
DNMT1 | Epigenetics | Colon cancer | Du et al., 2010; Bronner,2011 |
SUMO | Lecona et al.,2016 | ||
LSD1 | Medulloblastoma | Yi et al.,2016 | |
CHK1 | DNA damage and repair | Alonso-de Vega et al.,2014 | |
UVSSA | Sarasin, 2012; Zhang et al.,2012 | ||
ANXA1 | Hela | Park et al.,2015 | |
XPC | He et al.,2014 | ||
HLTF, Rad18 | Qing et al.,2011 | ||
Polη | Qian et al.,2015 | ||
RNF168 | Breast cancer | Malapelle et al.,2017 | |
PHF8 | Breast cancer | Wang Q. et al.,2016 | |
MDC1 | Cervical cancer | Su et al.,2018 | |
Wnt/β-catenin signaling pathway | Several canonical signaling pathways | Colorectal cancer | Novellasdemunt et al.,2017 |
NF-κB signaling pathway | Multiple myeloma | Colleran et al.,2013 | |
NOTCH signaling pathway | Lymphoblastic leukemia | Shan et al.,2018 |